Ursodiol
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
 | |
| Clinical data | |
|---|---|
| Synonyms | ursodeoxycholic acid, Actigall, Ursofalk, Urso, Urso Forte |
| Identifiers | |
| |
| CAS Number | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C24H40O4 |
| Molar mass | 392.56 g/mol |
| 3D model (JSmol) | |
| Melting point | 203 °C (397.4 °F) |
| |
|
WikiDoc Resources for Ursodiol |
|
Articles |
|---|
|
Most recent articles on Ursodiol |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Ursodiol at Clinical Trials.gov Clinical Trials on Ursodiol at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Ursodiol
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Ursodiol Risk calculators and risk factors for Ursodiol
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Ursodiol |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Ursodiol, also known as ursodeoxycholic acid and the abbreviation UDCA, is one of the secondary bile acids, which are metabolic byproducts of intestinal bacteria. Primary bile acids are produced by the liver and stored in the gall bladder. When secreted into the colon, primary bile acids can be metabolized into secondary bile acids by intestinal bacteria. Primary and secondary bile acids help the body digest fats. Ursodeoxycholic acid helps regulate cholesterol by reducing the rate at which the intestine absorbs cholesterol molecules while breaking up micelles containing cholesterol. Because of this property, ursodeoxycholic acid is used to treat (cholesterol) gallstones non-surgically.
While some bile acids are known to be colon tumor promoters (eg. deoxycholic acid), others such as ursodeoxycholic acid are chemopreventive, perhaps by inducing cellular differentiation and/or cellular senescence in colon epithelial cells.[1]
Ursodeoxycholic acid has also been shown experimentally to suppress immune response such as immune cell phagocytosis. Increased quantities of systemic (throughout the body, not just in the digestive system) ursodeoxycholic acid can be toxic.
Bile acids are important signaling molecules that help regulate the regrowth of liver tissue, recent research has shown. Ursodeoxycholic acid has been used as an experimental tool in liver regrowth studies. There is a possible link between the immune-repression and liver-regeneration properties of this substance, but clinical studies have yet to confirm these suspicions.
As a pharmaceutical
Ursodeoxycholic acid goes by the trade names Actigall, Ursofalk, Urso, and Urso Forte. At least in Italy, it is marketed under the name Deursil.
Ursodeoxycholic acid can be chemically synthesized and was brought to market by the Montreal-based Axcan Pharma in 1998, which continues to market the drug.
The drug reduces cholesterol absorption and is used to dissolve (cholesterol) gallstones in patients who want an alternative to surgery. The drug is very expensive, however, and if the patient stops taking it, the gallstones recur. For these reasons, it has not supplanted surgical treatment by cholecystectomy.
It is used to treatment primary biliary cirrhosis and other cholestatic diseases.[2][3] In children it is used in biliary atresia,[2] which is a cause of neonatal jaundice.
Ursodeoxycholic acid reduces elevated liver enzyme levels by facilitating bile flow through the liver and protecting liver cells.
The drug is generally not derived from animals. However, it is believed more than 12,000 bile bears are kept on farms in China, Vietnam and South Korea for the purpose of harvesting ursodeoxycholic acid.[4] Ursodeoxycholic acid is found in large quantities in bear bile.
References
- ↑ Akare S, Jean-Louis S, Chen W, Wood DJ, Powell AA, Martinez JD (2006). "Ursodeoxycholic acid modulates histone acetylation and induces differentiation and senescence". Int. J. Cancer. 119 (12): 2958–69. doi:10.1002/ijc.22231. PMID 17019713.
- ↑ 2.0 2.1 Smith T, Befeler AS (2007). "High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis". Current gastroenterology reports. 9 (1): 54–9. PMID 17335678.
- ↑ Jackson H, Solaymani-Dodaran M, Card TR, Aithal GP, Logan R, West J (2007). "Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: A population-based cohort study". 46 (4): 1131–1137. doi:10.1002/hep.21795. PMID 17685473.
- ↑ Richard Black (11 Jun 2007). "BBC Test kit targets cruel bear trade". BBC News.
External links
- Pages with script errors
- CS1 maint: Multiple names: authors list
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs
- Bile acids